Clinical trial

Comparison of Delivery Routes of Flu Vaccine in Adults

NCT00170547 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed

Key facts

NCT number NCT00170547
Title Comparison of Delivery Routes of Flu Vaccine in Adults
Official title Immunogenicity and Safety of a Split, Inactivated, Trivalent Influenza Vaccine Administered by Intradermal Route Compared to an Intramuscular Vaccination With Fluzone(R) in Healthy Adults
Lead sponsor National Institute of Allergy and Infectious Diseases (NIAID), NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Influenza
Intervention type Biological
Interventions Trivalent inactivated influenza vaccine
Enrollment 1,597
Start date Sep 1, 2005
Primary completion Jan 1, 2006
Completion Feb 1, 2006
First posted Sep 15, 2005
Last update posted Dec 5, 2014
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies